In Silico Analysis of Bioactive Compounds from Sea Urchin (Echinometra mathaei) against SARS-COV-2

Angelica Kresnamurti, Farizah Izazi, Ersanda Nurma Praditapuspa, Siswandono

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


SARS-CoV-2 is a kind of coronavirus that produces Covid-19 illness, which is still a public health concern in Indonesia. Meanwhile, an effective drug has not yet been found and although vaccination has been carried out, in several regions and neighboring countries there is still an increase in Covid-19 cases. This study aimed to obtain bioactive compounds from sea urchins (Echinometra mathaei) that have greater antiviral potential and lower toxicity than remdesivir. This research was started by predicting druglikeness with SwissADME, followed ADMET predicition with pkCSM online, and docking of molecule using the Molegro Virtual Docker (MVD) 5.5 software against the main protease (Mpro) target (PDB ID: 6W63). The results showed that six compounds from sea urchins (Echinometra mathaei) had antiviral activity, where the bioactive compound from sea urchins (Echinometra mathaei) with the highest affinity was shown by Spinochrome C a smaller rerank score compared with Remdesivir and native ligand (X77). So that Spinochrome C compounds are candidates as SARS-CoV-2 inhibitors potential developed drug.

Original languageEnglish
Pages (from-to)329-337
Number of pages9
JournalBiomedical and Pharmacology Journal
Issue number1
Publication statusPublished - 2023


  • Druglikeness
  • SARS-COV-2
  • Sea urchin
  • molecular docking


Dive into the research topics of 'In Silico Analysis of Bioactive Compounds from Sea Urchin (Echinometra mathaei) against SARS-COV-2'. Together they form a unique fingerprint.

Cite this